Establishment of a humanized animal model of systemic sclerosis in which T helper-17 cells from patients with systemic sclerosis infiltrate and cause fibrosis in the lungs and skin
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Establishment of a humanized animal model of systemic sclerosis in which T helper-17 cells from patients with systemic sclerosis infiltrate and cause fibrosis in the lungs and skin' 의 참고문헌
Understanding fibrosis in systemic sclerosis:shifting paradigms, emerging opportunities
Transfer of PBMC From SSc Patients Induces Autoantibodies and Systemic Inflammation in Rag2-/-/IL2rg-/-Mice
Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis
Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin
The pathogenesis of systemic sclerosis
Th17 peripheral cells are increased in diffuse cutaneous systemic sclerosis compared with limited illness : a cross-sectional study
Targeting human plasmacytoid dendritic cells through BDCA2prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma
Targeted therapies for systemic sclerosis
TGF-β stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Standardized quantification of pulmonary fibrosis in histological samples
Scleroderma-like alterations in collagen metabolism occurring in the TSK(tight skin)mouse
STAT3 regulates cytokine-mediated generation of inflammatory helper T cells
Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1induction
Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlaninduced spondyloarthritis
Rebamipide attenuates autoimmune arthritis severity in SKG mice via regulation of B cell and antibody production
Proposition of a novel animal model of systemic sclerosis induced by type V collagen in C57BL/6 mice that reproduces fibrosis, vasculopathy and autoimmunity
Phosphorylated signal transducer and activator of transcription 3(pSTAT3)is highly expressed in CD14+circulating cells of scleroderma patients
Neutrophil extracellular traps are present in immune-complexmediated cutaneous small vessel vasculitis and correlate with the production of reactive oxygen species and the severity of vessel damage
Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase
Murine sclerodermatous graft-versus-host disease, a model for human scleroderma : cutaneous cytokines, chemokines, and immune cell activation
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis
Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g
Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement
Increased interleukin-17 production in patients with systemic sclerosis
Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction
Increased frequencies of circulating CXCL10-, CXCL8-and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients
Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts
Immune modulation by rebamipide in a mouse model of Sjogren’s syndrome via T and B cell regulation
IL-1-IL-17 signaling axis contributes to fibrosis and inflammation in two different murine models of systemic sclerosis
Humanized mouse models of clinical disease
Human lymphoid and myeloid cell development in NOD/LtSzscid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells
Formation and function of the myofibroblast during tissue repair
Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art
Earliest phase of systemic sclerosis typified by increased levels of inflammatory proteins in the serum
Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null)mice
Cur l 3, a major allergen of Curvularia lunataderived short synthetic peptides, shows promise for successful immunotherapy
Chemokines in rheumatic diseases : pathogenic role and therapeutic implications
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Animal models of systemic sclerosis : prospects and limitations
Animal models of scleroderma : recent progress
Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma
2013 classification criteria for systemic sclerosis : an American College of Rheumatology/European League against Rheumatism collaborative initiative
'
Establishment of a humanized animal model of systemic sclerosis in which T helper-17 cells from patients with systemic sclerosis infiltrate and cause fibrosis in the lungs and skin'
의 유사주제(
